Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02872025
Brief Title: Pembrolizumab in High-risk Ductal Carcinoma in Situ (DCIS)

First Submitted : August 10, 2016
First Submitted that Met QC Criteria : August 15, 2016
First Posted : August 18, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : January 26, 2021
Last Update Posted : January 29, 2021